SELLAS (SLS) is a publicly traded Healthcare sector company. As of August 26, 2026, SLS trades at $13.64 with a market cap of $2.89B and a P/E ratio of -56.80. SLS moved -2.98% today. Year to date, SLS is +223.91%; over the trailing twelve months it is +637.70%. Its 52-week range spans $0.85 to $15.88. Analyst consensus is buy with an average price target of $27.50. Rallies surfaces SLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks SLS insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $13.64 |
| Market Cap | $2.89B |
| P/E Ratio | -56.80 |
| EPS | $-0.25 |
| Dividend Yield | 0.24% |
| 52-Week High | $15.88 |
| 52-Week Low | $0.85 |
| Volume | 2.34M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.86M |
| Gross Margin | 0.00% |
2 analysts cover SLS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.50.